IP Verse

Dorries competitive analysis

Loading summary...

Explore patent oppositions filed by Dorries against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 30, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3313373	A Stable Liquid Formulation Of Fusion Protein With Igg Fc Domain	ALTEOGEN	Aug 25, 2025
EP3824879	A Stable Liquid Formulation Of Fusion Protein With Igg Fc Domain	ALTEOGEN	Aug 25, 2025
EP3684786	Mutated Glycoprotein Of Vesicular Stomatitis Virus	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS	May 14, 2025
EP3227447	Guide Rna With Chemical Modifications	AGILENT	Jan 22, 2025
EP4069368	Enhancing Blood-Brain Barrier Drug Transport By Targeting Endogenous Regulators	THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY	Jan 15, 2025
EP3110848	Methods For Treating Skin Infection By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Nov 13, 2024
EP3515465	Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R Inhibitor	REGENERON PHARMACEUTICALS	Nov 7, 2024
EP3791896	Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer	ASTELLAS PHARMA	Oct 10, 2024
EP3973987	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Oct 1, 2024
EP3703818	Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist	REGENERON PHARMACEUTICALS	Aug 1, 2024

Explore the latest publications and patents granted to Dorries, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Dorries, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Dorries with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 30, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
DR H ULRICH DORRIES	26	-	-	-
GENENTECH	-	87	-	65
REGENERON PHARMACEUTICALS	38	94	9	31
SANOFI BIOTECHNOLOGY	-	51	-	-